Last50.69 -0.76 (-1.48%)
49.35 - 127.2
52 Week Range
Technical Indicators (Daily)
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland.
Emergent BioSolutions Announces Initiation of Pivotal Phase 3 Study Evaluating the Safety and Immunogenicity of Its Single-Dose Chikungunya Vaccine Candidate, CHIKV VLP
GAITHERSBURG, Md., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the first participant dosed in its pivotal phase 3 study evaluating the safety and immunogeni...
Did You Acquire (EBS) Before April 24, 2020? Johnson Fistel Investigates Emergent; Should Management be Held Accountable for Investors Losses?
SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating potential claims on behalf of Emergent BioSolutions Inc. ("Emergent" or the "Company") (NYSE: EBS) against certain of ...
Emergent BioSolutions Inc. (NYSE:EBS) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
It is hard to get excited after looking at Emergent BioSolutions' (NYSE:EBS) recent performance, when its stock has......
DENVER, September 21, 2021--Shuamn, Glenn & Stecker investigates Emergent BioSolutions, Inc. (NYSE: EBS)....
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....
Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.